In this interview with Dr. Satyajit Rath, we talk about the recent studies done on COVID-19 across the globe. We also look at the state of the vaccines under trial and the delivery mechanisms
In this interview with scientist Satyajit Rath, we talk about whether the world is any closer to reaching herd immunity. He also talks about the situation in India
Even if the major economies can solve their own problems of procuring the vaccines by jumping the queue with money or captive production capacities, what about the rest of the world?
Immunologist Dr. Satyajit Rath talks about the decision of the US Food and Drug Administration to declare September 3 as the potential target date for the release of a vaccine for COVID-19
Cuba’s vaccine candidate is the first from the Latin America and the Caribbean region and marks a continuation of its pioneering work in combating COVID-19 across the world
Dr. Satyajit Rath talks about the immunity developed in recovered COVID-19 patients and also the immunity that the potential vaccines can induce.
Dr. Satyajit Rath talks to Peoples Dispatch about the recent announcement made by Russian president Vladimir Putin declaring that the country has developed a vaccine for COVID-19.
India has third highest number of COVID-19 cases in the world and is recording close to or over 50,000 cases a day. What explains this relentless surge in cases in the country?
With rich countries and big pharma companies getting proactive, there is widespread apprehension about access and price of the vaccine for countries that need it most.
Newsclick’s Prabir Purkayastha talks about the US decision to leave the World Health Organization. He points out that this is yet another instance of US exceptionalism and describes how the country iis one of the largest beneficiaries of WHO’s vaccine program.
Newsclick’s Prabir Purkayastha discusses the US buying out supplies of the COVID-19 drug, Remdesivir.
In a trial, Dexamethasone, an inexpensive and widely used corticosteroid, reduced deaths by one-third in ventilated patients and by one-fifth in patients receiving oxygen support